Org.nr 917 359 725 2022 → 2023 Year-over-year analysis

3P BIOTECH HOLDING AS: årsregnskap 2023 vs 2022

Cash halved-plus

approved 2024-06-26; registry 2024-08-12; journal 2024 724078

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2023 with 2022 for 3P BIOTECH HOLDING AS. Net result -17.0k NOK → -19.1k NOK. Equity -11.4k NOK → -30.5k NOK.

Pressures included: operating result weakened; net result weakened; equity eroded.

Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for 3P BIOTECH HOLDING AS.

Scorecard

Operating result
-17.0k NOK -19.1k NOK
-12.8%
Net result
-17.0k NOK -19.1k NOK
-12.9%
Equity
-11.4k NOK -30.5k NOK
-168.3%
Cash
462 NOK -195.5k NOK
-42407.8%
Total assets
n/m 7.55m NOK
—

What deteriorated

  • ↓

    Operating result weakened

    Operating result -17.0k NOK → -19.1k NOK. Calculated

  • ↓

    Net result weakened

    Net result -17.0k NOK → -19.1k NOK. Calculated

  • ↓

    Equity eroded

    Book equity -11.4k NOK → -30.5k NOK. Calculated

  • ↓

    Cash fell

    Bank deposits 462 NOK → -195.5k NOK (-42407.8% YoY). Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is -0.4% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation